Evidence map›Paper›PMID 35893468›Full record

ReviewJournal of functional biomaterials2022

Hydroxyapatite Nanoparticles for Improved Cancer Theranostics.

Saeid Kargozar, Sahar Mollazadeh, Farzad Kermani, Thomas J Webster, Simin Nazarnezhad, Sepideh Hamzehlou, Francesco Baino

Open access · goldAbstract readReview
In one paragraph

Review in Journal of functional biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. 3D Bioprinting in Limb Salvage Surgery.Journal of functional biomaterials · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 5 countries.

Saeid KargozarTissue Engineering Research Group (TERG), Department of Anatomy and Cell Biology, School of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.ORCID 0000-0002-3785-1322
Sahar MollazadehDepartment of Materials Engineering, Faculty of Engineering, Ferdowsi University of Mashhad (FUM), Azadi Square, Mashhad 9177948564, Iran.
Farzad KermaniDepartment of Materials Engineering, Faculty of Engineering, Ferdowsi University of Mashhad (FUM), Azadi Square, Mashhad 9177948564, Iran.ORCID 0000-0002-7290-3570
Thomas J WebsterPrograma de Pós-Graduação em Ciência e Engenharia dos Materiais, Universidade Federal do Piauí, Teresina 64049-550, Brazil.
Simin NazarnezhadTissue Engineering Research Group (TERG), Department of Anatomy and Cell Biology, School of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.ORCID 0000-0001-9174-0685
Sepideh HamzehlouGenetics Laboratory, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad 9176699199, Iran.
Francesco BainoInstitute of Materials Physics and Engineering, Department of Applied Science and Technology (DISAT), Politecnico di Torino, 10129 Torino, Italy.ORCID 0000-0001-8860-0497
Mashhad University of Medical Sciences · IRFerdowsi University of Mashhad · IRHebei University of Technology · CNPolitecnico di Torino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beyond their well-known applications in bone tissue engineering, hydroxyapatite nanoparticles (HAp NPs) have also been showing great promise for improved cancer therapy. The chemical structure of HAp NPs offers excellent possibilities for loading and delivering a broad range of anticancer drugs in a sustained, prolonged, and targeted manner and thus eliciting lower complications than conventional chemotherapeutic strategies. The incorporation of specific therapeutic elements into the basic composition of HAp NPs is another approach, alone or synergistically with drug release, to provide advanced anticancer effects such as the capability to inhibit the growth and metastasis of cancer cells through activating specific cell signaling pathways. HAp NPs can be easily converted to smart anticancer agents by applying different surface modification treatments to facilitate the targeting and killing of cancer cells without significant adverse effects on normal healthy cells. The applications in cancer diagnosis for magnetic and nuclear in vivo imaging are also promising as the detection of solid tumor cells is now achievable by utilizing superparamagnetic HAp NPs. The ongoing research emphasizes the use of HAp NPs in fabricating three-dimensional scaffolds for the treatment of cancerous tissues or organs, promoting the regeneration of healthy tissue after cancer detection and removal. This review provides a summary of HAp NP applications in cancer theranostics, highlighting the current limitations and the challenges ahead for this field to open new avenues for research.

Indexed as

bioceramicscancer treatmenthydroxyapatitenanomaterials

Identifiers

PMID35893468
PMCPMC9326646
OpenAlexW4286209500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.